Novo A/S »

Dyne Therapeutics shares owned by Novo A/S

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Novo A/S

Quarter filed Position value Share count Share price at filing
2026-06-30 $21M 960k 22.21

More positions owned by Novo A/S

Edgewise Therapeutics (EWTX)
Asml Holding N V N Y Registry Shs (ASML)
Hemab Therapeutics Hldgs Com Shs
Brookfield Corp Cl A Ltd Vt Sh (BN)
Maplight Therapeutics (MPLT)
Mirum Pharmaceuticals (MIRM)
Avalyn Pharmaceuticals Com Shs
salesforce (CRM)
Arrivent Biopharma (AVBP)
Enliven Therapeutics (ELVN)
Crinetics Pharmaceuticals In (CRNX)
Pharvaris N V (PHVS)
Floor & Decor Hldgs Cl A (FND)
Vaxcyte (PCVX)
4d Molecular Therapeutics In (FDMT)

View all positions for Novo A/S

Top funds holding Dyne Therapeutics

Henderson Group
BlackRock
Jupiter Topco
FMR
Orbis Allan Gray
Atlas Venture Life Science Advisors
State Street Corporation
Vanguard Capital Management
TCG Crossover Management
Vanguard Portfolio Management
Fcpm Iii Services B.v.
Geode Capital Management
Vestal Point Capital
OrbiMed Advisors
Frazier Life Sciences Management

View all funds holding Dyne Therapeutics